Company Filing History:
Years Active: 2021
Title: Éric Bergeron: Innovator in Biomolecular Delivery Systems
Introduction
Éric Bergeron is a notable inventor based in Saint-Jean-sur-Richelieu, Canada. He has made significant contributions to the field of biomolecular delivery systems, particularly in the context of ocular applications. His innovative approach has the potential to enhance therapeutic interventions for eye-related conditions.
Latest Patents
Éric Bergeron holds a patent for a method and system for delivering exogenous biomolecules into the eye. The patent describes a process that involves injecting a mixture of exogenous biomolecules and plasmonic structures into a specific region of the eye. The plasmonic structures, which have a plasmonic resonance wavelength, are designed to adjoin the membranes of target cells. By irradiating the region with a laser beam, the plasmonic structures create pores in the membranes of the target cells. This allows for the effective delivery of biomolecules into the cells, facilitating potential therapeutic benefits.
Career Highlights
Éric Bergeron is affiliated with École Polytechnique, where he continues to advance research in biomolecular delivery systems. His work is characterized by a commitment to innovation and the application of cutting-edge technology in the medical field. With a patent portfolio that includes one significant patent, he demonstrates a strong focus on practical solutions to complex problems.
Collaborations
Éric Bergeron has collaborated with esteemed colleagues such as Michel Meunier and Ariel Wilson. These partnerships have contributed to the development and refinement of his innovative methods, enhancing the impact of his research in the field.
Conclusion
Éric Bergeron's contributions to the field of biomolecular delivery systems exemplify the intersection of innovation and practical application. His patented method for delivering biomolecules into the eye represents a significant advancement in ocular therapeutics. Through his work at École Polytechnique and collaborations with fellow researchers, he continues to push the boundaries of what is possible in medical technology.